This content is machine translated Osteoporosis: Special cases Insufficiency fracture in a premenopausal patient In young patients with inadequate fractures, secondary osteoporosis should be investigated. Osteodensitometry is particularly useful if there are anamnestic risk factors, whereby it is important to assess the z-score, as...…
View Post 5 min This content is machine translated Osteoporosis How patients benefit most from osteoporosis therapeutics Osteoporosis therapeutics have been proven to be effective in reducing the risk of vertebral and non-vertebral fractures. Ideally, they should be used as part of a multimodal therapy and tailored…
View Post 11 min This content is machine translated Osteoporosis New in diagnostics and therapy Since 2018, the update of the S3 guideline Prophylaxis, Diagnosis and Therapy of Osteoporosis (AWMF 183-001) took place after previous update of the underlying PICO questions (Population-Intervention-Comparison-Outcome questions) for systematic… CME-Test
View Post 11 min This content is machine translated Osteoporosis New in diagnostics and therapy Since 2018, the update of the S3 guideline Prophylaxis, Diagnosis and Therapy of Osteoporosis (AWMF 183-001) took place after previous update of the underlying PICO questions (Population-Intervention-Comparison-Outcome questions) for systematic… CME-Test
View Post 7 min This content is machine translated CKD-MBD Therapy of osteoporosis in chronic renal insufficiency Renal dysfunction leads to serious changes in bone density and mineralization. These irregularities are grouped under the term CKD-MBD (Chronic Kidney Disease – Mineral and Bone Disorder) . A review…
View Post 3 min This content is machine translated Osteoporosis treatment according to needs What’s new? The American College of Physicians (ACP) published an updated 2023 guideline on drug therapy for patients with reduced bone density or osteoporosis. An extensive secondary analysis published last year has…
View Post 3 min This content is machine translated Management of osteoporosis Reduction of fracture risk through specific osteoporosis medication Osteoporosis leads to an increased risk of fracture due to the loss of bone mass and density. The indication for therapy is mainly based on fracture history, bone density (DXA)…
View Post 6 min This content is machine translated Osteoporosis Clarify risk patients densitometrically and treat them in an individualized manner The risk of suffering an osteoporosis-related fracture is significantly increased with certain predisposing factors. This should be increasingly taken into account because, according to the Swiss Association against Osteoporosis (SVGO),…
View Post 5 min This content is machine translated Osteoporosis Management Match sequential long-term treatment to individual fracture risk According to guideline recommendations, individualized long-term measures must be adapted to the personal risk profile and disease activity. The overriding treatment goal is the best possible reduction of future fracture risk. To…
View Post 6 min This content is machine translated Swiss Association against Osteoporosis (SVGO) Toolbox for osteoporosis management: update of recommendations. Osteoporosis is a wide-ranging health problem, but there are a variety of preventive and therapeutic options available today. Early detection and risk stratification are important prerequisites for patient-adapted prevention and…
View Post 3 min This content is machine translated Bisphosphonates in osteoporosis The benefit outweighs the risk Since their introduction in the 1990s, bisphosphonates have been the drugs of first choice in the treatment of osteoporosis. They inhibit osteoclast-mediated resorption and bone remodeling, increase bone mineral density,…
